Home/Filings/4/0001104659-20-013511
4//SEC Filing

Hagerman Philip R 4

Accession 0001104659-20-013511

CIK 0001610092other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 4:16 PM ET

Size

37.6 KB

Accession

0001104659-20-013511

Insider Transaction Report

Form 4
Period: 2020-02-10
Hagerman Philip R
DirectorChairman and CEO10% Owner
Transactions
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh313,337$1,253,3480 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh394,910$1,579,6400 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh1,475,876$5,903,5040 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh3,391,609$13,566,4360 total(indirect: 2007 Hagerman Family GST)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh3,600,091$14,400,3640 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh1,475,876$5,903,5040 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh1,311,292$5,245,1680 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh313,337$1,253,3480 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh367,256$1,469,0240 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh2,612$10,44833,259 total
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh313,337$1,253,3480 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh367,528$1,470,1120 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh272,000$1,088,0000 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh394,910$1,579,6400 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh1,280,099$5,120,3960 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh1,075,293$4,301,1720 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh313,337$1,253,3480 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh263,500$1,054,0000 total(indirect: By Trust)
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh367,256$1,469,0240 total(indirect: By Trust)
  • Disposition to Issuer

    Common Stock

    2020-02-10$4.00/sh33,259$133,0360 total
Footnotes (4)
  • [F1]Represents shares tendered to the Denali Merger Sub, Inc. ("Purchaser") in connection with the closing on February 10, 2020 of a cash tender offer by Purchaser to acquire common stock of Issuer in exchange for $4.00 per share in cash, subject to any required withholding of taxes, without interest.
  • [F2]Pursuant to an Agreement and Plan of Merger, dated December 9, 2019 (the "Merger Agreement"), by and among UnitedHealth Group Incorporated, a Delaware corporation ("Parent"), Purchaser, a Michigan corporation and a wholly owned subsidiary of Parent and Diplomat Pharmacy, Inc., a Michigan corporation (the "Issuer"), each outstanding restricted stock award held by reporting person was disposed of pursuant to the closing on February 10, 2020 of the merger of Purchaser with and into the Issuer.
  • [F3]These shares are indirectly owned by Mr. Hagerman as the trustee of the Philip R. Hagerman Revocable Trust, The JH GST Trust, the 2013 Irrevocable Exempt Trusts and 2014 Irrevocable Exempt Trusts for two daughters, and the JH Marital Trust.
  • [F4]Jocelyn Hagerman is Mr. Hagerman's wife. These shares are indirectly owned by her, with Mr. Hagerman acting as the trustee of the 2007 Hagerman Family GST Trust, the 2013 Irrevocable Exempt Trusts and 2014 Irrevocable Exempt Trusts for a son and daughter, and the Jocelyn Hagerman Living Trust. Mrs. Hagerman is the co-trustee with Mr. Hagerman of the PH Marital Trust.

Documents

1 file

Issuer

Diplomat Pharmacy, Inc.

CIK 0001610092

Entity typeother

Related Parties

1
  • filerCIK 0001618897

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:16 PM ET
Size
37.6 KB